XORTX Therapeutics Inc (TSE:XRTX) has released an update.
XORTX Therapeutics Inc. has successfully closed a $1.5 million registered direct offering and concurrent private placement. The company plans to use the proceeds for working capital and general corporate purposes. This financial maneuver reflects XORTX’s ongoing efforts to advance its innovative therapies for kidney disease.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
